MDLN
Medline Inc.
Key Financials
Revenue
$28.4B
↑ 11.5%
Operating Income
$2.2B
↑ 3.1%
Gross Profit
$7.5B
↑ 7.8%
EPS (Diluted)
$-0.01
0.0%
Shareholders' Equity
$10.7B
N/A
Total Assets
$38.5B
↑ 7.0%
Cash & Equivalents
$1.9B
↑ 874.4%
Total Liabilities
$19.2B
↓ 1.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| SCHEDULE 13G/A | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| SCHEDULE 13G | 8/6/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| 8-K | 7/9/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MDLN |
| Company Name | Medline Inc. |
| CIK | 2046386 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 847-949-3000 |